Executive Lookbook

• M.D., McGill University

• Director, Osher Center for Integrative Medicine
• Professor-in-residence of medicine at Harvard Medical School

• Served as director of the Osher Center for Integrative Medicine, jointly based at Brigham and Women's Hospital and Harvard Medical School, and professor-in-residence of medicine at Harvard Medical School.
• Served as a visiting professor of neurological sciences at the University of Vermont Larner College of Medicine, Burlington.
• Her research interests have centered around the role of connective tissue in low back pain and the mechanisms of acupuncture, manual, and movement-based therapies. Her recent work focuses on the effects of stretching on inflammation resolution mechanisms within connective tissue.
• Completed her postdoctoral research fellowship in neurochemistry at the Medical Research Council Neurochemical Pharmacology Unit in Cambridge, England, and a residency in internal medicine and fellowship in endocrinology and metabolism at The Johns Hopkins Hospital in Baltimore.

• Ph.D., The American University

• B.S., University of Massachusetts, Amherst

• Former Extramural Director of the Division of Basic Neuroscience and Behavioral Research.
• Recipient of several NIH Director's Awards.

• Ph.D., The American University

• B.S., University of Massachusetts, Amherst

• Former Extramural Director of the Division of Basic Neuroscience and Behavioral Research.
• Recipient of several NIH Director's Awards.

M.D., University of Zagreb 

• Clinical Professor, University of Washington
• Professor of Neurology, University of Wisconsin
• Pain Franchise Executive Director, Contract Research Organizations
• Supervisory Clinical Physician, NCCIH

• Development of neuropathology pain questionnaire. 
• Established the role of Quantitative Sensory Testing for pain disorders.
• Developed innovative models of early phase pain clinical trials.

• B.S., Frostburg State University

• Deputy Executive Officer, NCCIH
• Senior Administrative Officer, NIDCR

• Recipient of NIH Director's Award and the OD Honor Award.
• Graduate of NIH Senior Leadership Program.

• M.D. Stanford University 
• Ph.D., Stanford University 
• M.M.H.C., Vanderbilt University 
• B.SA., University of Northern Iowa 

• Chair, Department of Medicine, Physician-in-Chief – Vanderbilt University Medical Center
• Deputy Director, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
• Director, Division of Hematology and Oncology – Vanderbilt University Medical Center
• Associate Professor, Associate Direct - University of North Carolina at Chapel Hill

• Elected to the National Academy of Medicine – for pioneering work in kidney cancer and creating pathways to support physician-scientist career development.
• First woman to receive the Eugene P. Schonfeld Award from the Kidney Cancer Association 
• Recipient of the Paragon Award for Research Excellence from the Doris Duke Foundation 
• Elected to the American Academy of Arts and Science – for contributions to cancer biology and career development
• Winner of the 2020 American Association for Cancer Research Team Science Award for contributions to The Cancer Genome Atlas

• M.D., NYU School of Medicine
• B.A., Amherst College

• Co-Developer of the Human Papilloma Virus (HPV) vaccine.
• 2007 Federal Employee of the Year.
• 2011 Sabin Gold Medal
• 2014 National Medal of Technology and Innovation.
• 2017 Lasker~DeBakey Clinical Medical Research Award

Ph.D., Columbia University

• Director, Division of Cancer Biology, NCI
• Senior Investigator, Experimental Immunology Branch, Center for Cancer Research, NCI

• Known for characterization of the molecular mechanisms regulating transcription of Major Histocompatibility Class I genes
• Discovered mechanisms coordinating chromatin structure and transcription, and mechanisms linking transcription and translation
• Developed research networks to advance studies in mouse models of human cancer, cancer systems biology, tumor microenvironment
• Led NCI’s Cancer Moonshot effort 

• Ph.D., California Institute of Technology
• B.S., Michigan Technology University

• Professor and Vice Chai, Biostatics and Bioinformatics, Duke University School of Medicine

• Fellow of the American College of Medical Informatics (FACMI)
• Advocate for open science, open software, open ontologies
• Co-founder of the Cancer Informatics for Cancer Centers (Ci4CC) Society

• M.D., Ph.D., Loma Linda University

• Deputy Chief, Laboratory of Tumor Immunology and Biology
• CCR, NCI Chief, Genitourinary Malignancies Branch,
• CCR, NCI Director, Medical Oncology Service, CCR, NCI  

• Known for expertise in immunotherapy, having designed and conducted >100 clinical trials from first-in-human / first-in-class therapies to randomized controlled registration endpoint studies.
• 2010 Presidential Early Career Award for Scientists and Engineers, the highest award bestowed by the US President on investigators early in their careers.
• 2018 Hubert H. Humphrey Award for Service to America for contributing to the health, safety, and well-being of the nation by helping to get FDA approval for avelumab for Merkel cell carcinoma and urothelial carcinoma.
• Multiple other awards including 10 NCI or NIH Director’s Awards. 

• B. A. Biology - U. California, San Diego
• Ph.D. Microbiology& Immunoloy, U. California, Los Angeles

• Deputy Director, CCR, NCI 
• Deputy Chief, Pediatric Oncology Branch, CCR, NCI
• Senior Investigator, Pediatric Oncology Branch, CCR, NCI 
• Damon-Runyan Walter Winchell Research Fellow 
• Cancer Research Institute Fellow

• Scientific expertise in molecular genetics and epigenetics of pediatric solid tumors, especially neuroblastoma
• Know for preclinical research using retinoids to target MYCN oncogene and induce neuroblastoma differentiation which led to clinical trials and inclusion of retinoids in therapy for patients with high-risk neuroblastoma.
• Recipient of a number of NIH, NCI awards for science and mentoring 
• Founding Editor of Cell Death & Differentiation journal. 

• MD, Duke University School of Medicine
• BS, North Carolina State University

• Deputy Director, Center for Cancer Research

• Known for expertise in the management of localized prostate cancer and radiorecurrent prostate cancer. 
• Internationally recognized expert in normal tissue radiobiology and radiation toxicity.
• Recipient of multiple NIH and NCI Director's Awards, including the Ruth L. Kirschstein Mentoring Award and the Alan S. Rabson Award for Clinical Care.

• M.D., Harvard Medical School
• A.B., Princeton University

• Chief, Pediatric Oncology Branch, NCI
• Acting Chief, Medical Oncology Branch, NCI

• Author of over 800 scientific papers
• Leading expert on the discovery and characterization of cancer susceptibility regions in the human genome
• Medical Director for Camp Fantastic , a week-long recreational camp for pediatric cancer patients, which is a joint venture of the NCI and Special Love, Inc.

M.D., University of Vermont College of Medicine

B.S., Worcester Polytechnic Institute 

• Research Scholar, Howard Hughes Medical Institute/National Institutes of Health Research Scholars Program, Laboratory of Pathology, National Cancer Institute, National Institutes of Health
• Attending Physician,  Pediatric Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health
• Investigator, Tenure-Track: Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD

• NIH Merit Award, Individual, for developing DCEG’s Genetic Epidemiology of Telomere Maintenance in Cancer Etiology research program, and discovering the TINF2 dyskeratosis congenita susceptibility gene
• Elected to Society for Pediatric Research
• Elected to American Society for Clinical Investigation
• NCI Outstanding Mentor Award, National Cancer Institute, NIH
• NCI Director’s Award of Merit for COVID-19 Pandemic Infrastructure and Administration Leadership
• Robert H. Goddard Alumni Award for Outstanding Professional Achievement, Worcester Polytechnic Institute

• M.D., Ph.D., Loma Linda University

• Deputy Chief, Laboratory of Tumor Immunology and Biology
• CCR, NCI Chief, Genitourinary Malignancies Branch,
• CCR, NCI Director, Medical Oncology Service, CCR, NCI  

• Known for expertise in immunotherapy, having designed and conducted >100 clinical trials from first-in-human / first-in-class therapies to randomized controlled registration endpoint studies.
• 2010 Presidential Early Career Award for Scientists and Engineers, the highest award bestowed by the US President on investigators early in their careers.
• 2018 Hubert H. Humphrey Award for Service to America for contributing to the health, safety, and well-being of the nation by helping to get FDA approval for avelumab for Merkel cell carcinoma and urothelial carcinoma.
• Multiple other awards including 10 NCI or NIH Director’s Awards.